545 related articles for article (PubMed ID: 11525641)
1. Rho family GTPases regulate VEGF-stimulated endothelial cell motility.
Soga N; Namba N; McAllister S; Cornelius L; Teitelbaum SL; Dowdy SF; Kawamura J; Hruska KA
Exp Cell Res; 2001 Sep; 269(1):73-87. PubMed ID: 11525641
[TBL] [Abstract][Full Text] [Related]
2. Growth factor induced activation of Rho and Rac GTPases and actin cytoskeletal reorganization in human lens epithelial cells.
Maddala R; Reddy VN; Epstein DL; Rao V
Mol Vis; 2003 Jul; 9():329-36. PubMed ID: 12876554
[TBL] [Abstract][Full Text] [Related]
3. Differential regulation of sphingosine-1-phosphate- and VEGF-induced endothelial cell chemotaxis. Involvement of G(ialpha2)-linked Rho kinase activity.
Liu F; Verin AD; Wang P; Day R; Wersto RP; Chrest FJ; English DK; Garcia JG
Am J Respir Cell Mol Biol; 2001 Jun; 24(6):711-9. PubMed ID: 11415936
[TBL] [Abstract][Full Text] [Related]
4. FGF-2 induced reorganization and disruption of actin cytoskeleton through PI 3-kinase, Rho, and Cdc42 in corneal endothelial cells.
Lee HT; Kay EP
Mol Vis; 2003 Dec; 9():624-34. PubMed ID: 14685150
[TBL] [Abstract][Full Text] [Related]
5. Cysteine-rich and basic domain HIV-1 Tat peptides inhibit angiogenesis and induce endothelial cell apoptosis.
Jia H; Lohr M; Jezequel S; Davis D; Shaikh S; Selwood D; Zachary I
Biochem Biophys Res Commun; 2001 May; 283(2):469-79. PubMed ID: 11327725
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin II type 2 receptor inhibits vascular endothelial growth factor-induced migration and in vitro tube formation of human endothelial cells.
Benndorf R; Böger RH; Ergün S; Steenpass A; Wieland T
Circ Res; 2003 Sep; 93(5):438-47. PubMed ID: 12881481
[TBL] [Abstract][Full Text] [Related]
7. Rac regulates vascular endothelial growth factor stimulated motility.
Soga N; Connolly JO; Chellaiah M; Kawamura J; Hruska KA
Cell Commun Adhes; 2001; 8(1):1-13. PubMed ID: 11775025
[TBL] [Abstract][Full Text] [Related]
8. Regulation of TNF-alpha-induced reorganization of the actin cytoskeleton and cell-cell junctions by Rho, Rac, and Cdc42 in human endothelial cells.
Wójciak-Stothard B; Entwistle A; Garg R; Ridley AJ
J Cell Physiol; 1998 Jul; 176(1):150-65. PubMed ID: 9618155
[TBL] [Abstract][Full Text] [Related]
9. Temporally and spatially coordinated roles for Rho, Rac, Cdc42 and their effectors in growth cone guidance by a physiological electric field.
Rajnicek AM; Foubister LE; McCaig CD
J Cell Sci; 2006 May; 119(Pt 9):1723-35. PubMed ID: 16595546
[TBL] [Abstract][Full Text] [Related]
10. Kaposi's sarcoma cells of different etiologic origins respond to HIV-Tat through the Flk-1/KDR (VEGFR-2): relevance in AIDS-KS pathology.
Morini M; Benelli R; Giunciuglio D; Carlone S; Arena G; Noonan DM; Albini A
Biochem Biophys Res Commun; 2000 Jun; 273(1):267-71. PubMed ID: 10873597
[TBL] [Abstract][Full Text] [Related]
11. Novel role of ARF6 in vascular endothelial growth factor-induced signaling and angiogenesis.
Ikeda S; Ushio-Fukai M; Zuo L; Tojo T; Dikalov S; Patrushev NA; Alexander RW
Circ Res; 2005 Mar; 96(4):467-75. PubMed ID: 15692085
[TBL] [Abstract][Full Text] [Related]
12. HGF/NK4 inhibited VEGF-induced angiogenesis in in vitro cultured endothelial cells and in vivo rabbit model.
Nakabayashi M; Morishita R; Nakagami H; Kuba K; Matsumoto K; Nakamura T; Tano Y; Kaneda Y
Diabetologia; 2003 Jan; 46(1):115-23. PubMed ID: 12637990
[TBL] [Abstract][Full Text] [Related]
13. Evidence that PI3K, Rac, Rho, and Rho kinase are involved in basic fibroblast growth factor-stimulated fibroblast-Collagen matrix contraction.
Abe M; Sogabe Y; Syuto T; Yokoyama Y; Ishikawa O
J Cell Biochem; 2007 Dec; 102(5):1290-9. PubMed ID: 17497700
[TBL] [Abstract][Full Text] [Related]
14. A novel, quantitative model for study of endothelial cell migration and sprout formation within three-dimensional collagen matrices.
Vernon RB; Sage EH
Microvasc Res; 1999 Mar; 57(2):118-33. PubMed ID: 10049660
[TBL] [Abstract][Full Text] [Related]
15. Regulation of cancer cell motility through actin reorganization.
Yamazaki D; Kurisu S; Takenawa T
Cancer Sci; 2005 Jul; 96(7):379-86. PubMed ID: 16053508
[TBL] [Abstract][Full Text] [Related]
16. Blockade of EphA receptor tyrosine kinase activation inhibits vascular endothelial cell growth factor-induced angiogenesis.
Cheng N; Brantley DM; Liu H; Lin Q; Enriquez M; Gale N; Yancopoulos G; Cerretti DP; Daniel TO; Chen J
Mol Cancer Res; 2002 Nov; 1(1):2-11. PubMed ID: 12496364
[TBL] [Abstract][Full Text] [Related]
17. Insulin-like growth factor binding protein-7 (IGFBP7) blocks vascular endothelial cell growth factor (VEGF)-induced angiogenesis in human vascular endothelial cells.
Tamura K; Hashimoto K; Suzuki K; Yoshie M; Kutsukake M; Sakurai T
Eur J Pharmacol; 2009 May; 610(1-3):61-7. PubMed ID: 19374835
[TBL] [Abstract][Full Text] [Related]
18. Serum response factor is a critical requirement for VEGF signaling in endothelial cells and VEGF-induced angiogenesis.
Chai J; Jones MK; Tarnawski AS
FASEB J; 2004 Aug; 18(11):1264-6. PubMed ID: 15180964
[TBL] [Abstract][Full Text] [Related]
19. Phosphorylation of tyrosine 1214 on VEGFR2 is required for VEGF-induced activation of Cdc42 upstream of SAPK2/p38.
Lamalice L; Houle F; Jourdan G; Huot J
Oncogene; 2004 Jan; 23(2):434-45. PubMed ID: 14724572
[TBL] [Abstract][Full Text] [Related]
20. Complete inhibition of vascular endothelial growth factor (VEGF) activities with a bifunctional diabody directed against both VEGF kinase receptors, fms-like tyrosine kinase receptor and kinase insert domain-containing receptor.
Lu D; Jimenez X; Zhang H; Wu Y; Bohlen P; Witte L; Zhu Z
Cancer Res; 2001 Oct; 61(19):7002-8. PubMed ID: 11585724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
